Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings
January 16, 2025
In this podcast, Dr. Tracy Anderson-Haag, Dr. Sandra Kane-Gill, and Dr. Andrew Webb discuss the AJHP Primer, “Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Tracy Anderson-Haag, Pharm.D., BCPS, BCTXP is a Clinical Pharmacist in Transplantation at Hennepin Healthcare. She earned her PharmD from the University of Minnesota and completed a 2-year Nephrology/Transplantation Residency at Hennepin Healthcare. She is board certified in pharmacotherapy and solid organ transplant. She serves as the Engagement Co-Lead for the Advancing Kidney Health through Optimal Medication Management (AKHOMM) initiative which aims to ensure every person with chronic kidney disease receives optimal medication management through team-based care including a pharmacist.
Sandra L. Kane-Gill, Pharm.D., MSc, FCCP, FCCM is a professor of pharmacy and therapeutics and associate dean of faculty affairs and programmatic innovation at the University of Pittsburgh School of Pharmacy. Dr. Kane-Gill is a critical care medication safety pharmacist in the Department of Pharmacy at UPMC. Her research focuses on effective approaches for the detection, prevention, and management of medication errors and adverse drug events with emphasis on drug associated acute kidney injury.
Andrew Webb, Pharm.D., BCCCP is a neurocritical care clinical pharmacy specialist at Massachusetts General Hospital. He is originally from Rhode Island and completed his undergraduate studies and Doctor of Pharmacy at the University of Rhode Island, followed by PGY1 pharmacy residency at Mayo Clinic and PGY2 in critical care at Oregon Health & Science University. His clinical and research interests include status epilepticus, subarachnoid hemorrhage, traumatic brain injury, and optimizing neurocritically ill patient care through appropriate medication use.
Daniel J. Cobaugh, Pharm.D., FAACT, DABAT is the senior vice president of professional development and publishing at ASHP and the editor-in-chief of AJHP. He has served on the ASHP staff since 2002. He received his B.S. in Pharmacy from the University of Pittsburgh and his Doctor of Pharmacy from Duquesne University. Cobaugh completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT